Joshua Daniel

Joshua Daniel is an accomplished scientist specializing in upstream process development within the biotechnology field. Currently serving as Principal Associate Scientist at Kelonia Therapeutics since October 2022, Joshua previously held various roles at TCR² Therapeutics Inc., progressing from Research Associate to Senior Associate Scientist II between August 2019 and September 2022. Earlier experience includes a position as R&D Technician at Quansys Biosciences, where Joshua focused on developing multiplexed ELISA assays and gained skills in antibody labeling and protein degradation analysis. Joshua's foundational research skills were honed as an Undergraduate Researcher at Utah State University and as a team member for a capstone project with GE Healthcare, exploring bioreactor systems and their impact on cell growth. Joshua holds a Bachelor's Degree in Biological Engineering from Utah State University and a Graduate Certificate in Biotechnology from Tufts University.